SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-079595
Filing Date
2022-03-18
Accepted
2022-03-18 17:03:12
Documents
12
Period of Report
2021-12-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d280036d8ka.htm   iXBRL 8-K/A 22766
  Complete submission text file 0001193125-22-079595.txt   152982

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA logc-20211221.xsd EX-101.SCH 2861
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20211221_lab.xml EX-101.LAB 19446
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20211221_pre.xml EX-101.PRE 12145
6 EXTRACTED XBRL INSTANCE DOCUMENT d280036d8ka_htm.xml XML 4360
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38707 | Film No.: 22753285
SIC: 2836 Biological Products, (No Diagnostic Substances)